Safi Biosolutions
Arlington
About Safi Biosolutions
As the cell therapy commercialization partner of a 5-year Department of Defense program to manufacture on-demand blood products, Safi Biosolutions and its collaborators are working to ‘crack the code’ of Cell Therapy 2.0 challenges of manufacturing at appropriate scale, high consistency of product, and economically viable cost of goods by integrating world-leading expertise in cord blood stem cell expansion, bioprocessing optimization, manufacturing scale-up and cryostorage.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $8.5M
- Funding stage: Seed
- Last round: Grant (Apr 2025)
- Website: safi.bio
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/safi-biosolutions-92793 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.